Endoscopic Retrograde Cholangiopancreatography Devices Market Size, Share, and COVID-19 Impact Analysis-Global-2022-2028-MedCore-Includes: Sphincterotome Market, Bilary Stone Removal Balloon Market, and 6 more

Endoscopic Retrograde Cholangiopancreatography Devices Market Size, Share, and COVID-19 Impact Analysis-Global-2022-2028-MedCore-Includes: Sphincterotome Market, Bilary Stone Removal Balloon Market, and 6 more

The total global endoscopic retrograde cholangiopancreatography (ERCP) device market is growing at a rate of 6%, which will take the 2021 market value of $1.7 billion up to $2.6 billion by 2028.

The full report suite on the global market for ERCP devices includes sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary dilation balloons, biliary and pancreatic stents, biliary lithotripters, ERCP guidewires and ERCP cannulas.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

PROCEDURE NUMBERS

In 2021, ERCP procedures saw a strong increase as the previous procedures that were delayed due to the COVID-19 pandemic were finally able to be conducted. Throughout the forecast period, procedural growth is expected to return to pre-COVID levels and growth steadily over the next few years.

GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET TRENDS

Within the global ERCP market, the largest segment was the biliary and pancreatic stent market in 2021. This segment has experienced significant growth since Boston Scientific acquired Xlumena in 2015 and began marketing its AXIOS™ lumen-apposing covered-metal stent.

GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET SHARE INSIGHTS

Overall, within the global ERCP device market there are three dominant competitors: Boston Scientific, Olympus, Cook Medical.Boston Scientific managed to be the leader of the ERCP market in 2021. Boston Scientific has experienced significant growth since acquiring Xlumena and its AXIOS™ lumen-apposing covered-metal stent in 2015.

MARKET SEGMENTATION SUMMARY

Sphincterotome
Biliary Stone Removal Balloon
Biliary Stone Removal Basket
Biliary Dilation Balloon
Biliary and Pancreatic Stent
Biliary Lithotripter
ERCP Guidewire
ERCP Cannula

RESEARCH SCOPE SUMMARY

Regions – North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year – 2021
Forecast – 2022-2028
Historical Data – 2018-2021
Quantitative Coverage – Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage – COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources – Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.